Showing results (2041-2050 of 2,418) with videos related to
Sort By:
Pageof 242
Annales De Pathologie|March 18, 2014
[Peritoneal pseudomyxoma: an overview emphasizing pathological assessment and therapeutic strategies]Peggy Dartigues, Sylvie Isaac, Laurent Villeneuve, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2019
Allogeneic Stem Cell Transplantation in Therapy-Related Myelodysplasia after Autologous Transplantation for Lymphoma: A Retrospective Study of the Francophone Society of Bone Marrow Transplantation and Cellular TherapyDaniel Jaimes-Albornoz, Lionel Mannone, Stéphanie Nguyen-Quoc, et al.Nature|February 22, 2023
Diagnosing destabilization risk in global land carbon sinksMarcos Fernández-Martínez, Josep Peñuelas, Frederic Chevallier, et al.BJUI Compass|January 29, 2025
Does the transfer of knowledge from the pioneer generation to the second-generation speed-up the learning curve of robot-assisted partial nephrectomies? TRANSFER trial (UroCCR n°83)Louis Vignot, Zine-Eddine Khene, Adil Mellouki, et al.American Journal of Hematology|August 31, 2024
Higher survival following transplantation with a mismatched unrelated donor with posttransplant cyclophosphamide-based graft-versus-host disease prophylaxis than with double unit umbilical cord blood in patients with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationFrédéric Baron, Myriam Labopin, Jurjen Versluis, et al.Movement Ecology|December 19, 2024
A benchmark for computational analysis of animal behavior, using animal-borne tagsBenjamin Hoffman, Maddie Cusimano, Vittorio Baglione, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 2019
Influence of Donor Type (Sibling versus Matched Unrelated Donor versus Haploidentical Donor) on Outcomes after Clofarabine-Based Reduced-Intensity Conditioning Allograft for Myeloid MalignanciesLouise Bouard, Thierry Guillaume, Pierre Peterlin, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 19, 2022
Effective Letermovir Prophylaxis of CMV infection post allogeneic hematopoietic cell transplantation: Results from the French temporary authorization of use compassionate programDavid Beauvais, Christine Robin, Anne Thiebaut, et al.British Journal of Haematology|February 22, 2011
l-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005-01 randomized trialCarine Domenech, Xavier Thomas, Sylvie Chabaud, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 11, 2015
Outcomes of Cord Blood Transplantation Using Reduced-Intensity Conditioning for Chronic Lymphocytic Leukemia: A Study on Behalf of Eurocord and Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation, and the Societé Française de Greffe de Moelle et Therapie CellulaireErick Xavier, Jérôme Cornillon, Annalisa Ruggeri, et al.Pageof 242